Back to search

France· FR:63404771

PYLCLARI 1 500 MBq/mL, solution injectable

A piflufolastat (18f) product containing piflufolastat (18f), registered in France by CURIUM PET FRANCE. The same ATC class is registered in 10 of our 19 countries.

ATC V09IX16

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedPYLCLARI 1 500 MBq/mL, solution injec…ATCV09IX16REGISTER NO.FR:63404771PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Piflufolastat (18f) is registered in 10 of 19 countries.

Countries holding a registration under ATC V09IX16 (piflufolastat (18f)), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 7 of them publish a price we can compare per daily dose

Piflufolastat (18f) · ATC V09IX16

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
PIFLUFOLASTAT (18F)
Manufacturer
CURIUM PET FRANCE
Country
France (FR)
ATC code
V09IX16
ATC class
Piflufolastat (18F)
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955097440
    1 flacon en verre de 15 mL

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Piflufolastat (18f) in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All piflufolastat (18f) products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Pylclari
  • Norway · Pylclari

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/924d4985-bf69-4c1e-a979-de24c0ee682e
GET /v1/drugs/924d4985-bf69-4c1e-a979-de24c0ee682e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63404771",
  "date_amm": "2023-07-24",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/23/1746",
  "substance": "PIFLUFOLASTAT (18F)",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}

See everything about piflufolastat (18f).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.